Precision Biomonitoring receives funding to play an important role that will help increase COVID-19 testing in Canada

Precision Biomonitoring, an industry leader in point-of-need molecular detection tools, has announced that it has received approval and funding from Next Generation Manufacturing Canada (NGen) to support manufacturing needs for the production of its TripleLockTM SARS-CoV-2 Go-Strips.

The funding will enable Precision Biomonitoring to work directly with Canadian manufacturers to rapidly increase production of its SARS-CoV-2 Go-Strips, which will not only support Precision Biomonitoring, but also other Canadian biotech companies working to support the accessibility of molecular testing amidst COVID-19 and into the future.